| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neuroligin family protein binding | 1.76e-05 | 5 | 27 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | Notch binding | 6.05e-04 | 27 | 27 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 5.57e-06 | 1077 | 27 | 9 | GO:0098609 | |
| GeneOntologyBiologicalProcess | Tie signaling pathway | 1.65e-05 | 5 | 27 | 2 | GO:0048014 | |
| GeneOntologyBiologicalProcess | vasculature development | 2.30e-05 | 969 | 27 | 8 | GO:0001944 | |
| GeneOntologyBiologicalProcess | negative regulation of plasma membrane bounded cell projection assembly | 2.74e-05 | 45 | 27 | 3 | GO:0120033 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell chemotaxis | 5.91e-05 | 9 | 27 | 2 | GO:0071671 | |
| GeneOntologyBiologicalProcess | smooth muscle cell chemotaxis | 9.01e-05 | 11 | 27 | 2 | GO:0071670 | |
| GeneOntologyBiologicalProcess | adult behavior | 1.34e-04 | 203 | 27 | 4 | GO:0030534 | |
| GeneOntologyBiologicalProcess | blood vessel development | 1.48e-04 | 929 | 27 | 7 | GO:0001568 | |
| GeneOntologyBiologicalProcess | aorta development | 1.54e-04 | 80 | 27 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.58e-04 | 212 | 27 | 4 | GO:0003205 | |
| GeneOntologyBiologicalProcess | learning | 1.58e-04 | 212 | 27 | 4 | GO:0007612 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell differentiation | 1.71e-04 | 15 | 27 | 2 | GO:0045602 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.96e-04 | 16 | 27 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 2.38e-04 | 236 | 27 | 4 | GO:0061138 | |
| GeneOntologyBiologicalProcess | angiogenesis | 2.56e-04 | 708 | 27 | 6 | GO:0001525 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle cycle | 2.78e-04 | 19 | 27 | 2 | GO:0098693 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 3.09e-04 | 20 | 27 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 3.35e-04 | 258 | 27 | 4 | GO:0001763 | |
| GeneOntologyBiologicalProcess | circulatory system development | 3.74e-04 | 1442 | 27 | 8 | GO:0072359 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 4.47e-04 | 24 | 27 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 4.47e-04 | 24 | 27 | 2 | GO:0071625 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling, modulating synaptic transmission | 5.26e-04 | 26 | 27 | 2 | GO:0099550 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 5.50e-04 | 817 | 27 | 6 | GO:0048514 | |
| GeneOntologyBiologicalProcess | artery development | 6.85e-04 | 133 | 27 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 7.00e-04 | 134 | 27 | 3 | GO:0003279 | |
| GeneOntologyBiologicalProcess | positive regulation of cell junction assembly | 7.30e-04 | 136 | 27 | 3 | GO:1901890 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 9.02e-04 | 34 | 27 | 2 | GO:0097107 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.12e-03 | 619 | 27 | 5 | GO:0002009 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 1.19e-03 | 39 | 27 | 2 | GO:0003180 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 1.19e-03 | 161 | 27 | 3 | GO:0003206 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.25e-03 | 164 | 27 | 3 | GO:0099072 | |
| GeneOntologyBiologicalProcess | startle response | 1.31e-03 | 41 | 27 | 2 | GO:0001964 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 1.31e-03 | 41 | 27 | 2 | GO:0035025 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 1.31e-03 | 41 | 27 | 2 | GO:0035909 | |
| GeneOntologyBiologicalProcess | kidney development | 1.32e-03 | 372 | 27 | 4 | GO:0001822 | |
| GeneOntologyBiologicalProcess | learning or memory | 1.33e-03 | 373 | 27 | 4 | GO:0007611 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.38e-03 | 974 | 27 | 6 | GO:0034330 | |
| GeneOntologyBiologicalProcess | renal system development | 1.51e-03 | 386 | 27 | 4 | GO:0072001 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 1.51e-03 | 44 | 27 | 2 | GO:0098698 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.59e-03 | 178 | 27 | 3 | GO:0022612 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.65e-03 | 46 | 27 | 2 | GO:0003176 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 1.65e-03 | 46 | 27 | 2 | GO:1904861 | |
| GeneOntologyBiologicalProcess | branching involved in blood vessel morphogenesis | 1.72e-03 | 47 | 27 | 2 | GO:0001569 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.88e-03 | 410 | 27 | 4 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cell fate determination | 1.94e-03 | 50 | 27 | 2 | GO:0001709 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 1.94e-03 | 50 | 27 | 2 | GO:1905314 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 2.06e-03 | 195 | 27 | 3 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 2.06e-03 | 195 | 27 | 3 | GO:0007269 | |
| GeneOntologyBiologicalProcess | cognition | 2.11e-03 | 423 | 27 | 4 | GO:0050890 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 2.15e-03 | 198 | 27 | 3 | GO:0048754 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 2.44e-03 | 1090 | 27 | 6 | GO:0022603 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 2.56e-03 | 747 | 27 | 5 | GO:0007169 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 2.60e-03 | 750 | 27 | 5 | GO:0048729 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 2.61e-03 | 58 | 27 | 2 | GO:0097106 | |
| GeneOntologyCellularComponent | cell surface | 4.11e-05 | 1111 | 26 | 8 | GO:0009986 | |
| Domain | EGF_3 | 2.61e-11 | 235 | 27 | 9 | PS50026 | |
| Domain | EGF_1 | 5.42e-11 | 255 | 27 | 9 | PS00022 | |
| Domain | EGF_2 | 7.63e-11 | 265 | 27 | 9 | PS01186 | |
| Domain | EGF | 1.01e-09 | 235 | 27 | 8 | SM00181 | |
| Domain | EGF-like_dom | 1.59e-09 | 249 | 27 | 8 | IPR000742 | |
| Domain | EGF-like_CS | 2.31e-09 | 261 | 27 | 8 | IPR013032 | |
| Domain | ASX_HYDROXYL | 5.47e-09 | 100 | 27 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.78e-09 | 106 | 27 | 6 | IPR000152 | |
| Domain | EGF | 2.20e-08 | 126 | 27 | 6 | PF00008 | |
| Domain | hEGF | 6.92e-08 | 28 | 27 | 4 | PF12661 | |
| Domain | Growth_fac_rcpt_ | 2.65e-06 | 156 | 27 | 5 | IPR009030 | |
| Domain | - | 1.01e-05 | 95 | 27 | 4 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 1.09e-05 | 97 | 27 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.19e-05 | 99 | 27 | 4 | PS01187 | |
| Domain | LAM_G_DOMAIN | 2.20e-05 | 38 | 27 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 2.57e-05 | 40 | 27 | 3 | PF02210 | |
| Domain | EGF_CA | 2.71e-05 | 122 | 27 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.89e-05 | 124 | 27 | 4 | IPR001881 | |
| Domain | LamG | 3.43e-05 | 44 | 27 | 3 | SM00282 | |
| Domain | Syndecan | 4.21e-05 | 7 | 27 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 4.21e-05 | 7 | 27 | 2 | IPR027789 | |
| Domain | Laminin_G | 7.88e-05 | 58 | 27 | 3 | IPR001791 | |
| Domain | EGF_extracell | 8.73e-05 | 60 | 27 | 3 | IPR013111 | |
| Domain | EGF_2 | 8.73e-05 | 60 | 27 | 3 | PF07974 | |
| Domain | Ephrin_rec_like | 1.10e-04 | 11 | 27 | 2 | PF07699 | |
| Domain | Neurexin-like | 1.81e-04 | 14 | 27 | 2 | IPR003585 | |
| Domain | 4.1m | 1.81e-04 | 14 | 27 | 2 | SM00294 | |
| Domain | EGF_CA | 2.55e-04 | 86 | 27 | 3 | PF07645 | |
| Domain | ConA-like_dom | 2.61e-04 | 219 | 27 | 4 | IPR013320 | |
| Domain | Thyroglobulin_1 | 2.70e-04 | 17 | 27 | 2 | PF00086 | |
| Domain | TY | 2.70e-04 | 17 | 27 | 2 | SM00211 | |
| Domain | - | 2.70e-04 | 17 | 27 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_1 | 2.70e-04 | 17 | 27 | 2 | PS00484 | |
| Domain | THYROGLOBULIN_1_2 | 2.70e-04 | 17 | 27 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 2.70e-04 | 17 | 27 | 2 | IPR000716 | |
| Domain | Ephrin_rec_like | 5.92e-04 | 25 | 27 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.92e-04 | 25 | 27 | 2 | IPR011641 | |
| Domain | Peptidase_M12B_N | 1.44e-03 | 39 | 27 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.44e-03 | 39 | 27 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.52e-03 | 40 | 27 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 1.52e-03 | 40 | 27 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.52e-03 | 40 | 27 | 2 | PS50214 | |
| Domain | LDLR_class-A_CS | 1.52e-03 | 40 | 27 | 2 | IPR023415 | |
| Domain | Reprolysin | 1.52e-03 | 40 | 27 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 1.52e-03 | 40 | 27 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 1.59e-03 | 41 | 27 | 2 | IPR001762 | |
| Domain | Ldl_recept_a | 1.92e-03 | 45 | 27 | 2 | PF00057 | |
| Domain | - | 2.00e-03 | 46 | 27 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.18e-03 | 48 | 27 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.27e-03 | 49 | 27 | 2 | IPR002172 | |
| Domain | LDLa | 2.27e-03 | 49 | 27 | 2 | SM00192 | |
| Domain | LDLRA_2 | 2.27e-03 | 49 | 27 | 2 | PS50068 | |
| Domain | TSP_1 | 3.72e-03 | 63 | 27 | 2 | PF00090 | |
| Domain | Zinc_finger_PHD-type_CS | 3.96e-03 | 65 | 27 | 2 | IPR019786 | |
| Domain | TSP1 | 3.96e-03 | 65 | 27 | 2 | SM00209 | |
| Domain | TSP1_rpt | 3.96e-03 | 65 | 27 | 2 | IPR000884 | |
| Domain | TSP1 | 3.96e-03 | 65 | 27 | 2 | PS50092 | |
| Domain | PHD | 5.23e-03 | 75 | 27 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 5.79e-03 | 79 | 27 | 2 | IPR019787 | |
| Domain | MetalloPept_cat_dom | 6.08e-03 | 81 | 27 | 2 | IPR024079 | |
| Domain | - | 6.08e-03 | 81 | 27 | 2 | 3.40.390.10 | |
| Domain | TyrKc | 7.14e-03 | 88 | 27 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 7.14e-03 | 88 | 27 | 2 | IPR020635 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.15e-04 | 11 | 21 | 2 | M27882 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.34e-04 | 68 | 21 | 3 | M27303 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.38e-04 | 12 | 21 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.63e-04 | 13 | 21 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.50e-04 | 16 | 21 | 2 | M47424 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.84e-04 | 17 | 21 | 2 | M39389 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 7.25e-04 | 27 | 21 | 2 | M45550 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 7.25e-04 | 27 | 21 | 2 | M39545 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.02e-03 | 32 | 21 | 2 | MM15326 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.09e-03 | 33 | 21 | 2 | M39875 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.19e-03 | 143 | 21 | 3 | M27275 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.36e-03 | 37 | 21 | 2 | M39506 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.52e-03 | 39 | 21 | 2 | M27417 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.52e-03 | 39 | 21 | 2 | MM14604 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.52e-03 | 39 | 21 | 2 | MM15165 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.01e-03 | 45 | 21 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.10e-03 | 46 | 21 | 2 | MM15971 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 2.10e-03 | 46 | 21 | 2 | M48243 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.19e-03 | 47 | 21 | 2 | M7946 | |
| Pubmed | Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. | 1.46e-08 | 7 | 27 | 3 | 11344305 | |
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 9707552 | ||
| Pubmed | 1.27e-07 | 59 | 27 | 4 | 21421844 | ||
| Pubmed | 4.01e-07 | 19 | 27 | 3 | 20627076 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19658047 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 36044575 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 37543682 | ||
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 5.80e-07 | 2 | 27 | 2 | 9430716 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26387946 | ||
| Pubmed | SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma. | 5.80e-07 | 2 | 27 | 2 | 33027505 | |
| Pubmed | 8.35e-07 | 24 | 27 | 3 | 21633169 | ||
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 1.74e-06 | 3 | 27 | 2 | 34133920 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 38891114 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 1.74e-06 | 3 | 27 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 1.74e-06 | 3 | 27 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 1.74e-06 | 3 | 27 | 2 | 29045040 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 31005376 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 15939383 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 38571813 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 35173587 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 30858964 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 26341090 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 1.74e-06 | 3 | 27 | 2 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 1.74e-06 | 3 | 27 | 2 | 26446217 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 28013231 | ||
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 1.74e-06 | 3 | 27 | 2 | 11944992 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 16406382 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 1.74e-06 | 3 | 27 | 2 | 17035546 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 1.74e-06 | 3 | 27 | 2 | 25423136 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 31812984 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 14988227 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 3.48e-06 | 4 | 27 | 2 | 14983056 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 8786425 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 17347997 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 3.48e-06 | 4 | 27 | 2 | 32134527 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 32706374 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 17984306 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 3.48e-06 | 4 | 27 | 2 | 33888718 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 36376768 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 28472659 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 36709330 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 5.80e-06 | 5 | 27 | 2 | 18923512 | |
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 15882997 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 20537373 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 27118257 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 36205393 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 21602525 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 9223334 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 20554499 | ||
| Pubmed | Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1. | 7.05e-06 | 48 | 27 | 3 | 28924218 | |
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 17822320 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 8.69e-06 | 6 | 27 | 2 | 8576240 | |
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 8.69e-06 | 6 | 27 | 2 | 12244553 | |
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 30683685 | ||
| Pubmed | Notch4 reveals a novel mechanism regulating Notch signal transduction. | 8.69e-06 | 6 | 27 | 2 | 24667410 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 8.69e-06 | 6 | 27 | 2 | 12827191 | |
| Pubmed | A Jagged 1-Notch 4 molecular switch mediates airway inflammation induced by ultrafine particles. | 8.69e-06 | 6 | 27 | 2 | 29627423 | |
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 19816407 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 10079256 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 29782851 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 9856994 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.22e-05 | 7 | 27 | 2 | 12846471 | |
| Pubmed | 1.62e-05 | 8 | 27 | 2 | 16546160 | ||
| Pubmed | GluD1 is a signal transduction device disguised as an ionotropic receptor. | 1.62e-05 | 8 | 27 | 2 | 34135511 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 1.62e-05 | 8 | 27 | 2 | 30871858 | |
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.62e-05 | 8 | 27 | 2 | 12242716 | |
| Pubmed | 1.62e-05 | 8 | 27 | 2 | 9858718 | ||
| Pubmed | 1.62e-05 | 8 | 27 | 2 | 37591863 | ||
| Pubmed | 1.62e-05 | 8 | 27 | 2 | 22156581 | ||
| Pubmed | 2.08e-05 | 9 | 27 | 2 | 11118901 | ||
| Pubmed | 2.08e-05 | 9 | 27 | 2 | 16245338 | ||
| Pubmed | Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. | 2.08e-05 | 9 | 27 | 2 | 11944948 | |
| Pubmed | 2.08e-05 | 9 | 27 | 2 | 34919427 | ||
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 2.08e-05 | 9 | 27 | 2 | 10837027 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.60e-05 | 10 | 27 | 2 | 23665443 | |
| Pubmed | Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis. | 2.60e-05 | 10 | 27 | 2 | 17496152 | |
| Pubmed | Unique functions for Notch4 in murine embryonic lymphangiogenesis. | 2.60e-05 | 10 | 27 | 2 | 34665379 | |
| Pubmed | 3.18e-05 | 11 | 27 | 2 | 10878608 | ||
| Pubmed | The expression of Sox17 identifies and regulates haemogenic endothelium. | 3.18e-05 | 11 | 27 | 2 | 23604320 | |
| Pubmed | Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. | 3.18e-05 | 11 | 27 | 2 | 15875024 | |
| Pubmed | 3.18e-05 | 11 | 27 | 2 | 32973045 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 3.18e-05 | 11 | 27 | 2 | 15499562 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 3.18e-05 | 11 | 27 | 2 | 9187150 | |
| Pubmed | 3.18e-05 | 11 | 27 | 2 | 12866128 | ||
| Pubmed | 3.81e-05 | 12 | 27 | 2 | 15465494 | ||
| Pubmed | Lhx2 in germ cells suppresses endothelial cell migration in the developing ovary. | 3.81e-05 | 12 | 27 | 2 | 35337816 | |
| Pubmed | 3.81e-05 | 12 | 27 | 2 | 36082581 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.89e-05 | 248 | 27 | 4 | 24006456 | |
| Pubmed | Notch signaling is required for the maintenance of enteric neural crest progenitors. | 4.50e-05 | 13 | 27 | 2 | 18832397 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 4.50e-05 | 13 | 27 | 2 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 4.50e-05 | 13 | 27 | 2 | 20558824 | |
| Pubmed | 5.25e-05 | 14 | 27 | 2 | 28192800 | ||
| Pubmed | 5.25e-05 | 14 | 27 | 2 | 18528438 | ||
| Pubmed | Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression. | 5.25e-05 | 14 | 27 | 2 | 21402699 | |
| Pubmed | The contribution of rare and common variants in 30 genes to risk nicotine dependence. | 5.25e-05 | 14 | 27 | 2 | 25450229 | |
| Pubmed | Expression of insulin-like growth factor binding proteins during mouse cochlear development. | 5.25e-05 | 14 | 27 | 2 | 23813480 | |
| Pubmed | 5.25e-05 | 14 | 27 | 2 | 14757642 | ||
| Cytoband | 8p11.2 | 3.02e-05 | 14 | 27 | 2 | 8p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p11 | 1.69e-03 | 103 | 27 | 2 | chr8p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 2.95e-03 | 137 | 27 | 2 | chr9q31 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 7.97e-04 | 40 | 19 | 2 | 321 | |
| GeneFamily | PHD finger proteins | 3.97e-03 | 90 | 19 | 2 | 88 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.68e-03 | 394 | 19 | 3 | 471 | |
| Coexpression | NABA_MATRISOME | 5.38e-06 | 1008 | 27 | 8 | MM17056 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.21e-05 | 191 | 27 | 4 | MM17059 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 4.38e-05 | 193 | 27 | 4 | M6813 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.65e-05 | 196 | 27 | 4 | M3008 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 4.65e-05 | 196 | 27 | 4 | MM667 | |
| Coexpression | GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN | 4.74e-05 | 197 | 27 | 4 | M7258 | |
| Coexpression | NABA_MATRISOME | 6.16e-05 | 1026 | 27 | 7 | M5889 | |
| Coexpression | ROSS_AML_WITH_PML_RARA_FUSION | 7.60e-05 | 80 | 27 | 3 | M15368 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 7.76e-05 | 440 | 27 | 5 | M39039 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.08e-04 | 767 | 27 | 6 | M39209 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.16e-04 | 479 | 27 | 5 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.20e-04 | 483 | 27 | 5 | MM1082 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.22e-04 | 16 | 27 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.22e-04 | 16 | 27 | 2 | MM1296 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.56e-04 | 268 | 27 | 4 | M45796 | |
| Coexpression | NABA_CORE_MATRISOME | 1.60e-04 | 270 | 27 | 4 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.72e-04 | 275 | 27 | 4 | M5884 | |
| Coexpression | HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS | 1.73e-04 | 19 | 27 | 2 | MM420 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 1.92e-04 | 283 | 27 | 4 | M39117 | |
| Coexpression | DURAND_STROMA_S_UP | 2.40e-04 | 300 | 27 | 4 | M2581 | |
| Coexpression | DURAND_STROMA_S_UP | 2.52e-04 | 304 | 27 | 4 | MM1083 | |
| Coexpression | CLIMENT_BREAST_CANCER_COPY_NUMBER_UP | 2.55e-04 | 23 | 27 | 2 | M13910 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL | 2.78e-04 | 124 | 27 | 3 | M45673 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 5.05e-04 | 152 | 27 | 3 | M39239 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.75e-05 | 261 | 27 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 2.78e-05 | 734 | 27 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-09 | 189 | 27 | 6 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-09 | 191 | 27 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.68e-09 | 195 | 27 | 6 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-08 | 165 | 27 | 5 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-08 | 169 | 27 | 5 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.70e-08 | 177 | 27 | 5 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-08 | 178 | 27 | 5 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.09e-08 | 179 | 27 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.58e-08 | 186 | 27 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.81e-08 | 187 | 27 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 9.05e-08 | 188 | 27 | 5 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-08 | 189 | 27 | 5 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-08 | 189 | 27 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.54e-08 | 190 | 27 | 5 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.54e-08 | 190 | 27 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.54e-08 | 190 | 27 | 5 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.54e-08 | 190 | 27 | 5 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.79e-08 | 191 | 27 | 5 | 04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.79e-08 | 191 | 27 | 5 | db8dd6bbba803585bdd6a55d5c403d383f2e9acf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-07 | 192 | 27 | 5 | bacbaef1f230051335f4433e55db07a161b96b4c | |
| ToppCell | EC|World / Lineage and Cell class | 1.00e-07 | 192 | 27 | 5 | 478866dd5b0d6ff3a76d07a17c4b5989dd7a27bb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 193 | 27 | 5 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-07 | 193 | 27 | 5 | 3a9fe4e709c09ec787c71bdd6b58a71c419896de | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 193 | 27 | 5 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 193 | 27 | 5 | 6a623acd1adad9a78eddc32ffedb16352ad3fdfa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 193 | 27 | 5 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-07 | 193 | 27 | 5 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-07 | 194 | 27 | 5 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-07 | 194 | 27 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-07 | 194 | 27 | 5 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-07 | 194 | 27 | 5 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 195 | 27 | 5 | 517af3e6784f02c382df6f5691945eefaa9ec4ae | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-07 | 195 | 27 | 5 | 75db19c0371320ea5fce1d6de8c1b40b1e6a2e58 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-07 | 195 | 27 | 5 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-07 | 196 | 27 | 5 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.14e-07 | 197 | 27 | 5 | 21a1080e1db3a64f3eccc7aed2b3189332d31038 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.14e-07 | 197 | 27 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-07 | 197 | 27 | 5 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.14e-07 | 197 | 27 | 5 | 88859b7b24b36afab4a684fd7abf0e0f8e5b525c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-07 | 198 | 27 | 5 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-07 | 198 | 27 | 5 | f88198e11e835ad53d339c312f8f7b7b0b5c02d3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-07 | 199 | 27 | 5 | a3ec743b978ba8fdf1677b4971b5731f50ddd30f | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-07 | 199 | 27 | 5 | 9b02acae6325b0ac9642438a4431285ff396e5fe | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-07 | 199 | 27 | 5 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 200 | 27 | 5 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 200 | 27 | 5 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.33e-07 | 121 | 27 | 4 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 150 | 27 | 4 | 322aa0c3fc159a4b2897daac881dfc744b24ffc4 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.24e-06 | 155 | 27 | 4 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.66e-06 | 162 | 27 | 4 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 166 | 27 | 4 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 166 | 27 | 4 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 3.08e-06 | 168 | 27 | 4 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.38e-06 | 172 | 27 | 4 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.46e-06 | 173 | 27 | 4 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-06 | 174 | 27 | 4 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 3.54e-06 | 174 | 27 | 4 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | IPF-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 3.62e-06 | 175 | 27 | 4 | b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-06 | 176 | 27 | 4 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-06 | 176 | 27 | 4 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.96e-06 | 179 | 27 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.05e-06 | 180 | 27 | 4 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 4.14e-06 | 181 | 27 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.14e-06 | 181 | 27 | 4 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-06 | 183 | 27 | 4 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-06 | 183 | 27 | 4 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-06 | 184 | 27 | 4 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 4.51e-06 | 185 | 27 | 4 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 4.51e-06 | 185 | 27 | 4 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.71e-06 | 187 | 27 | 4 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 4.71e-06 | 187 | 27 | 4 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 188 | 27 | 4 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.81e-06 | 188 | 27 | 4 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 188 | 27 | 4 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.81e-06 | 188 | 27 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 4.91e-06 | 189 | 27 | 4 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-06 | 189 | 27 | 4 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.91e-06 | 189 | 27 | 4 | 1e1afa66b32ae752c0a42b02b80f10205464569c | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.91e-06 | 189 | 27 | 4 | 033a2be8bbb7bfb437e6f1657b6ca02070c74aa8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 5.01e-06 | 190 | 27 | 4 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 5.01e-06 | 190 | 27 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.01e-06 | 190 | 27 | 4 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.01e-06 | 190 | 27 | 4 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.01e-06 | 190 | 27 | 4 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.01e-06 | 190 | 27 | 4 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 191 | 27 | 4 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.12e-06 | 191 | 27 | 4 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.22e-06 | 192 | 27 | 4 | 7dbe3117a0f58ff2e838963d49f788a59a4351d7 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.22e-06 | 192 | 27 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 192 | 27 | 4 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 192 | 27 | 4 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 192 | 27 | 4 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.22e-06 | 192 | 27 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 192 | 27 | 4 | 144503af50274eaed5cf6effa892c640eab28663 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 192 | 27 | 4 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 192 | 27 | 4 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Early_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.22e-06 | 192 | 27 | 4 | 4986ef70a665fdfa1df86f7f8a15117487eae159 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 192 | 27 | 4 | c96736bb3a6bb052678b1b078f7823063ca69e6d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 192 | 27 | 4 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 192 | 27 | 4 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 2.81e-06 | 192 | 27 | 5 | 4152_DN | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.11e-06 | 196 | 27 | 5 | 6464_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.43e-06 | 200 | 27 | 5 | 4588_UP | |
| Drug | enzacamene | 1.56e-05 | 129 | 27 | 4 | ctd:C038939 | |
| Drug | octylmethoxycinnamate | 2.09e-05 | 139 | 27 | 4 | ctd:C118580 | |
| Drug | butylparaben | 3.37e-05 | 157 | 27 | 4 | ctd:C038091 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 6.95e-05 | 189 | 27 | 4 | 3733_DN | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; HL60; HT_HG-U133A | 6.95e-05 | 189 | 27 | 4 | 2508_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 7.54e-05 | 193 | 27 | 4 | 4253_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 7.69e-05 | 194 | 27 | 4 | 4141_DN | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; PC3; HT_HG-U133A | 8.00e-05 | 196 | 27 | 4 | 4256_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 4433_UP | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; HL60; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 2133_DN | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 3065_DN | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; HL60; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 3051_DN | |
| Drug | Procarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 3533_UP | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 27 | 4 | 6816_UP | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; HL60; HT_HG-U133A | 8.49e-05 | 199 | 27 | 4 | 2376_UP | |
| Drug | SC-58125; Up 200; 10uM; SKMEL5; HG-U133A | 8.49e-05 | 199 | 27 | 4 | 507_UP | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; HL60; HT_HG-U133A | 8.65e-05 | 200 | 27 | 4 | 2134_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A | 8.65e-05 | 200 | 27 | 4 | 5750_DN | |
| Drug | Androgen Antagonists | 9.49e-05 | 75 | 27 | 3 | ctd:D000726 | |
| Drug | glufosinate | 9.87e-05 | 76 | 27 | 3 | CID000004794 | |
| Drug | lead stearate | 1.33e-04 | 84 | 27 | 3 | CID000061258 | |
| Drug | isepamicin | 1.41e-04 | 15 | 27 | 2 | CID000003755 | |
| Drug | cefpirom | 1.41e-04 | 15 | 27 | 2 | CID004487900 | |
| Disease | ductal carcinoma in situ (is_implicated_in) | 1.69e-05 | 7 | 27 | 2 | DOID:0060074 (is_implicated_in) | |
| Disease | corpus callosum volume measurement | 1.04e-04 | 100 | 27 | 3 | EFO_0010299 | |
| Disease | longevity | 1.24e-04 | 284 | 27 | 4 | EFO_0004300 | |
| Disease | Uncinate Epilepsy | 2.02e-04 | 23 | 27 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 2.02e-04 | 23 | 27 | 2 | C0014556 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 2.02e-04 | 23 | 27 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 2.02e-04 | 23 | 27 | 2 | C0393682 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.20e-04 | 24 | 27 | 2 | C0887833 | |
| Disease | temperament and character inventory | 2.20e-04 | 24 | 27 | 2 | EFO_0004825 | |
| Disease | corpus callosum mid-anterior volume measurement | 2.79e-04 | 27 | 27 | 2 | EFO_0010297 | |
| Disease | caudate volume change measurement, age at assessment | 2.79e-04 | 27 | 27 | 2 | EFO_0008007, EFO_0021491 | |
| Disease | interleukin 5 measurement | 3.00e-04 | 28 | 27 | 2 | EFO_0008185 | |
| Disease | Malignant neoplasm of breast | 3.52e-04 | 1074 | 27 | 6 | C0006142 | |
| Disease | endometrial cancer (is_marker_for) | 4.71e-04 | 35 | 27 | 2 | DOID:1380 (is_marker_for) | |
| Disease | cervical cancer (is_marker_for) | 4.98e-04 | 36 | 27 | 2 | DOID:4362 (is_marker_for) | |
| Disease | hippocampal CA3 volume | 4.98e-04 | 36 | 27 | 2 | EFO_0009395 | |
| Disease | Malignant neoplasm of salivary gland | 7.79e-04 | 45 | 27 | 2 | C0220636 | |
| Disease | Osteosarcoma | 8.50e-04 | 47 | 27 | 2 | C0029463 | |
| Disease | Salivary Gland Neoplasms | 8.50e-04 | 47 | 27 | 2 | C0036095 | |
| Disease | multiple sclerosis (is_marker_for) | 9.23e-04 | 49 | 27 | 2 | DOID:2377 (is_marker_for) | |
| Disease | Schizophrenia | 1.11e-03 | 883 | 27 | 5 | C0036341 | |
| Disease | response to lithium ion | 1.20e-03 | 56 | 27 | 2 | GO_0010226 | |
| Disease | Mammary Neoplasms, Human | 1.26e-03 | 525 | 27 | 4 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 1.26e-03 | 525 | 27 | 4 | C4704874 | |
| Disease | Mammary Neoplasms | 1.27e-03 | 527 | 27 | 4 | C1458155 | |
| Disease | Breast Carcinoma | 1.37e-03 | 538 | 27 | 4 | C0678222 | |
| Disease | brain measurement, neuroimaging measurement | 1.49e-03 | 550 | 27 | 4 | EFO_0004346, EFO_0004464 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.64e-03 | 257 | 27 | 3 | DOID:10652 (is_marker_for) | |
| Disease | Autistic Disorder | 1.71e-03 | 261 | 27 | 3 | C0004352 | |
| Disease | radiation-induced disorder | 1.72e-03 | 67 | 27 | 2 | EFO_0009565 | |
| Disease | lymphocyte count | 1.78e-03 | 1464 | 27 | 6 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PCGLNQWICIDGVCM | 476 | Q99965 | |
| DWGQCSAQCGLGQQM | 1026 | Q9UKP5 | |
| GDWVCPNPSCGNMNF | 356 | Q92804 | |
| LSCQAGGCKGVQWMC | 426 | Q9BY79 | |
| MCSNGRCIPGAWQCD | 36 | Q86YD5 | |
| MNNNWHPGCFRCELC | 91 | Q7Z4I7 | |
| NGNINWNCPCLGGMA | 46 | Q8N4Q1 | |
| WNCICDIENCSNMAP | 186 | Q92633 | |
| QCKMSLNGQRGECWC | 271 | P18065 | |
| QGVCMQQWEGFTCDC | 1061 | Q9Y4C0 | |
| ACEDQQCCPEMGGWS | 126 | P27918 | |
| LSNPCKNNGMCRDGW | 681 | Q9ULB1 | |
| DQKNCNCCWAMAAAG | 146 | P56202 | |
| DINCGCPQRWAMAEG | 111 | O95620 | |
| GGWNSQMCCQGEQNP | 176 | Q92826 | |
| CDCLPGWMGQNCDIN | 436 | P78504 | |
| GWMGQNCDININDCL | 441 | P78504 | |
| ECQCWQHGVCMGLLE | 671 | Q9BVI0 | |
| CWNCGCEWNRVCMGD | 446 | O60260 | |
| NACSCPEGWMGRLCE | 3486 | Q4LDE5 | |
| PQCSCMPGWTGEQCQ | 141 | Q99466 | |
| PNLCSGNGQCMEWGC | 891 | Q8N2E2 | |
| MHPFQWCNGCFCGLG | 1 | Q9H9V4 | |
| CECQEGWMGPLCDQR | 1356 | O94813 | |
| WGPECNHLCTACMNN | 216 | Q02763 | |
| ECLSIEMPEGCWNCN | 936 | Q9BZ95 | |
| EMPEGCWNCNDCKAG | 941 | Q9BZ95 | |
| CDQAQGSCWCVMDSG | 1181 | P01266 | |
| MCGQQKECPGSWQQD | 551 | Q04912 |